Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 27, 2015	Jun. 28, 2014	Jun. 29, 2013
Cash flows from operating activities:
Net income	$ 206,038	$ 354,810	$ 454,912
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	79,491	85,452	83,808
Depreciation and amortization	299,396	244,593	207,136
Deferred taxes	(72,507)	(32,159)	25,372
Research and Development in Process	8,900	2,580	2,800
Loss (gain) from sale of property, plant and equipment	419	2,187	(1,156)
Tax benefit (shortfall) related to stock-based compensation	8,155	(68)	8,197
Excess tax benefit related to stock-based compensation	(12,549)	(14,192)	(18,923)
Net of Asset Impairment Charges	67,010	11,644	24,929
Goodwill, Impairment Loss	84,110	0	0
Gain (Loss) on Investments, Excluding Other than Temporary Impairments	94	10,260	700
Cash Provided by (Used in) Operating Activities, Discontinued Operations	(35,849)	0	(3,285)
Changes in assets and liabilities:
Accounts receivable	16,984	13,340	32,023
Inventories	2,163	20,672	(35,245)
Other current assets	(8,783)	45,557	(21,233)
Accounts payable	(4,201)	(11,255)	(32,510)
Income taxes payable	62,350	54,492	70,156
Deferred income on shipments to distributors	4,593	(823)	277
All other accrued liabilities	(12,108)	(10,983)	19,977
Net cash provided by operating activities	693,706	776,107	817,935
Cash flows from investing activities:
Purchases of property, plant and equipment	(75,816)	(132,523)	(216,672)
Proceeds from sale of property, plant, and equipment	29,035	5,293	19,196
Proceeds from Collection of Notes Receivable	0	0	10,786
Acquisitions	0	(459,256)	(2,767)
Cash Provided by (Used in) Investing Activities, Discontinued Operations	35,550	0	0
Purchases of available-for-sale securities	(25,142)	(49,953)	0
Payments to Acquire Investments	(200)	0	(500)
Proceeds from Divestiture of Businesses	500	0	585
Proceeds from sales/maturities of available-for-sale securities	0	27,000	50,000
Net cash used in investing activities	(36,073)	(609,439)	(139,372)
Cash flows from financing activities
Excess tax benefit from stock-based compensation plans	12,549	14,192	18,923
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	0	(4,705)	(13,781)
Repayment of notes payable	(437)	(4,708)	(303,500)
Long-term debt, net of issuance costs	0	497,895	494,395
Payments of Debt Issuance Costs	0	(3,431)	(3,921)
Proceeds from Issuance of Common Stock	(27,793)	(31,384)	(29,042)
Proceeds from Stock Options Exercised	58,587	69,639	71,342
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options	40,951	42,809	36,297
Repurchase of common stock	(195,088)	(305,314)	(375,135)
Dividends paid	(317,909)	(294,175)	(280,215)
Net cash used in financing activities	(429,140)	(19,182)	(384,637)
Net increase (decrease) in cash and cash equivalents	228,493	147,486	293,926
Cash and cash equivalents:
Beginning of year	1,322,472	1,174,986	881,060
End of year	1,550,965	1,322,472	1,174,986
Supplemental disclosures of cash flow information:
Cash (refunded) paid, net during the year for income taxes	40,500	(6,455)	19,080
Cash paid for interest	29,410	22,861	10,624
Noncash financing and investing activities:
Accounts payable related to property, plant and equipment purchases	4,921	14,474	16,825
Modification of Liability Instruments to Equity	$ 7,848	$ 0	$ 0